Patents Assigned to Jackson Lab.
  • Identification of a gene encoding TULP2, a retina specific protein
    Patent number: 5705380
    Abstract: The gene responsible for an autosomal dominant con-rod retinal dystrophy is identified, TULP2. The genes are used to produce the encoded protein; in screening for compositions that modulate the expression or function of TULP2 protein; and in studying associated physiological pathways.
    Type: Grant
    Filed: September 4, 1996
    Date of Patent: January 6, 1998
    Assignees: Sequana Theraputics, Inc., Jackson Lab.
    Inventors: Michael North, Patsy Nishina, Juergen Naggert
  • Treatment of obesity, diabetes and other symptoms of hypercorticoidism using etiocholanolones
    Patent number: 4666898
    Abstract: Obesity, diabetes obesity syndromes and associated hypercorticoidism are treated with .alpha. and/or .beta.-etiocholanolone.
    Type: Grant
    Filed: December 19, 1984
    Date of Patent: May 19, 1987
    Assignees: Jackson Lab., Progenics, Inc.
    Inventors: Douglas L. Coleman, Norman Applezweig